Utility of prognostic genomic tests in breast cancer practice: IMPAKT international expert consensus for utility of prognostic genomic tests in brea...

Date 10 May 2014
Event IMPAKT 2014
Session Should prognostic genomic tests be “routinely” used in clinical practice?
Topics Breast Cancer
Personalised Medicine
Translational Research
Presenter Martine Piccart
Authors H.A. Azim Jr.1, F. André2, G. Curigliano3, A. Di Leo4, C. Desmedt1, M. Dowsett5, P. Dubsky6, D.F. Hayes7, S. Michiels2, C..K. Osborne8, C.M. Perou9, J.S. Reis-Filho10, C. Sotiriou11, C. Swanton12, A. Thompson13, N. Turner14, A. Tutt14, G. Viale15, M. Piccart16
  • 1Medical Oncology, Institut Jules Bordet, Brussels/BE
  • 2Breast Cancer Unit, Department Of Medical Oncology, Institut de Cancérologie Gustave Roussy, 94800 - Villejuif/FR
  • 3Medicine, Istituto Europeo di Oncologia, 20141 - Milano/IT
  • 4"sandro Pitigliani" Medical Oncology Unit And Translational Research Unit, Hospital of Prato, "Sandro Pitigliani" Oncology Unit, Istituto Toscano Tumori, 59100 - Prato/IT
  • 5-, Royal Marsden Hospital NHS Foundation Trust, SW3 6JJ - London/UK
  • 6-, Vienna General Hospital (AKH) - Medizinische Universität Wien, 1090 - Vienna/AT
  • 7Internal Medicine, University of Michigan, 48109-5942 - Ann Arbor/US
  • 8-, Baylor College of Medicine, TX 77030 - Houston/US
  • 9-, Baylor College of Medicine, Chapel Hill/US
  • 10Department Of Pathology, Memorial Sloan-Kettering Cancer Center, 10065 - New York/US
  • 11Bctl - Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, 1000 - Brussels/BE
  • 12-, Francis Crick Institute, - - London/UK
  • 13Surgery And Molecular Oncology, University of Dundee, DD1 9SY - Dundee/UK
  • 14Breast Unit, Royal Marsden Hospital NHS Foundation Trust, SW3 6JJ - London/UK
  • 15Division Of Pathology, University Of Milan, School Of Medicine, Istituto Europeo di Oncologia, 20141 - Milano/IT
  • 16Head Of The Chemotherapy Department, Institut Jules Bordet, 1000 - Brussels/BE